{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T11:56:41Z","timestamp":1764935801716},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioDrugs"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s40259-016-0179-0","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T07:01:02Z","timestamp":1463468462000},"page":"353-359","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Choroidal Thickness Changes After Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration"],"prefix":"10.1007","volume":"30","author":[{"given":"Angelo Maria","family":"Minnella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Federici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetto","family":"Falsini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucilla","family":"Barbano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Gambini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Caporossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Savastano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"179_CR1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1076\/opep.11.2.67.28158","volume":"11","author":"D Pascolini","year":"2004","unstructured":"Pascolini D, Mariotti SP, Pokharel GP, et al. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol. 2004;11:67\u2013115.","journal-title":"Ophthalmic Epidemiol."},{"key":"179_CR2","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ophtha.2009.06.048","volume":"116","author":"NM Bressler","year":"2009","unstructured":"Bressler NM. Antiangiogenic approaches to age-related macular degeneration today. Ophthalmology. 2009;116:S15\u201323.","journal-title":"Ophthalmology."},{"key":"179_CR3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.survophthal.2012.01.006","volume":"57","author":"PA Keane","year":"2012","unstructured":"Keane PA, Patel PJ, Liakopoulos S, Heussen FM, Sadda SR, Tufail A. Evaluation of age-related macular degeneration with optical coherence tomography. Surv Ophthalmol. 2012;57:389\u2013414.","journal-title":"Surv Ophthalmol."},{"issue":"5035","key":"179_CR4","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.1957169","volume":"254","author":"D Huang","year":"1991","unstructured":"Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA, et al. Optical coherence tomography. Science. 1991;254(5035):1178\u201381.","journal-title":"Science."},{"key":"179_CR5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/eye.2013.78","volume":"27","author":"JH Kim","year":"2013","unstructured":"Kim JH, Kang SW, Kim JR, Kim SJ. Variability of subfoveal choroidal thickness measurements in patients with age-related macular degeneration and central serous chorioretinopathy. Eye. 2013;27:809\u201315.","journal-title":"Eye."},{"key":"179_CR6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1113\/jphysiol.2006.108753","volume":"575","author":"MP Walsh","year":"2006","unstructured":"Walsh MP, Marshall JM. The early effects of chronic hypoxia on the cardiovascular system in the rat: role of nitric oxide. J Physiol. 2006;575:263\u201375.","journal-title":"J Physiol."},{"key":"179_CR7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ajo.2014.07.006","volume":"158","author":"JJ Jung","year":"2014","unstructured":"Jung JJ, Chen CY, Mrejen S, et al. The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration. Am J Ophthalmol. 2014;158:769\u201379.","journal-title":"Am J Ophthalmol."},{"key":"179_CR8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.5301\/ejo.5000189","volume":"22","author":"G Coscas","year":"2012","unstructured":"Coscas G, Zhou Q, Coscas F, et al. Choroid thickness measurement with RTVue optical coherence tomography in emmetropic eyes, mildly myopic eyes, and highly myopic eyes. Eur J Ophthalmol. 2012;22:992\u20131000.","journal-title":"Eur J Ophthalmol."},{"key":"179_CR9","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.ophtha.2012.02.022","volume":"119","author":"T Yamazaki","year":"2012","unstructured":"Yamazaki T, Koizumi H, Yamagishi T, Kinoshita S. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results. Ophthalmology. 2012;119:1621\u20137.","journal-title":"Ophthalmology."},{"key":"179_CR10","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ajo.2015.08.009","volume":"160","author":"S Razavi","year":"2015","unstructured":"Razavi S, Souied EH, Darvizeh F, et al. Assessment of choroidal topographic changes by swept-source optical coherence tomography after ranibizumab for exudative age-related macular degeneration. Am J Ophthalmol. 2015;160:1006\u201313.","journal-title":"Am J Ophthalmol"},{"key":"179_CR11","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00417-011-1620-1","volume":"249","author":"H Koizumi","year":"2011","unstructured":"Koizumi H, Yamagishi T, Yamazaki T, et al. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. 2011;249:1123\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"179_CR12","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ophtha.2010.09.012","volume":"118","author":"SE Chung","year":"2011","unstructured":"Chung SE, Kang SW, Lee JH, Kim YT. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology. 2011;118:840\u20135.","journal-title":"Ophthalmology"},{"issue":"6","key":"179_CR13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/jop.2014.0160","volume":"31","author":"M Gharbiya","year":"2015","unstructured":"Gharbiya M, Cruciani F, Mariotti C, et al. Choroidal thickness changes after intravitreal antivascular endothelial growth factor therapy for age-related macular degeneration: ranibizumab versus aflibercept. J Ocul Pharmacol Ther. 2015;31(6):357\u201362.","journal-title":"J Ocul Pharmacol Ther."},{"key":"179_CR14","doi-asserted-by":"publisher","unstructured":"Kim JH, Lee TG, Chang YS, Kim CG, Cho SW. Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study. Br J Ophthalmol. 2016. doi: 10.1136\/bjophthalmol-2015-308074 .","DOI":"10.1136\/bjophthalmol-2015-308074"},{"key":"179_CR15","doi-asserted-by":"crossref","unstructured":"Yun C, Oh J, Ahn J, et al. Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2016 Jan 19. [Epub ahead of print].","DOI":"10.1007\/s00417-015-3260-3"},{"key":"179_CR16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.exer.2007.05.008","volume":"85","author":"J Lowe","year":"2007","unstructured":"Lowe J, Araujo J, Yang J, et al. Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo. Exp Eye Res. 2007;85:425\u201330.","journal-title":"Exp Eye Res"},{"key":"179_CR17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","volume":"26","author":"N Ferrara","year":"2006","unstructured":"Ferrara N, Damico L, Shams N, et al. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina. 2006;26:859\u201370.","journal-title":"Retina"},{"key":"179_CR18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1097\/IAE.0b013e318134eecd","volume":"27","author":"J Gaudreault","year":"2007","unstructured":"Gaudreault J, Fei D, Beyer JC, et al. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits. Retina. 2007;27:1260\u20136.","journal-title":"Retina"},{"key":"179_CR19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ajo.2012.03.047","volume":"154","author":"TU Krohne","year":"2012","unstructured":"Krohne TU, Liu Z, Holz FG, Meyer CH. Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans. Am J Ophthalmol. 2012;154:682\u20136.","journal-title":"Am J Ophthalmol."},{"key":"179_CR20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/978-1-4614-4711-5_3","volume":"763","author":"M Campbell","year":"2012","unstructured":"Campbell M, Humphries P. The blood\u2013retina barrier: tight junctions and barrier modulation. Adv Exp Med Biol. 2012;763:70\u201384.","journal-title":"Adv Exp Med Biol."}],"container-title":["BioDrugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-016-0179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40259-016-0179-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-016-0179-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T15:01:21Z","timestamp":1567868481000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40259-016-0179-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1007\/s40259-016-0179-0","relation":{},"ISSN":["1173-8804","1179-190X"],"issn-type":[{"value":"1173-8804","type":"print"},{"value":"1179-190X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]}}}